Barrett’s Esophagus in Romania: what do we know?
By:
References
- 1. SPECHLER SJ. Barrett’s esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis and therapy. Med Clin North Am 2002; 86(6):1423–45.
- 2. SHLAHEEN N, RANSOHOFF DF. Gastroesophageal reflux, Barrett esophagus and esophageal cancer: scientific review. Jama. 2002; 287(15):1972–1981.
- 3. BARR H. KENDALL C, BAZANT-HEGEMARK F, MOAYYEDI P, SHETTY G, STONE N. Endoscopic screening and surveillance for Barrett’s esophagus clinical implications. Med Gen Med 2006; 8:88.
- 4. SHARMA P, FALK GW, WESTON AP, REKER D, JOHNSON M, SAMPLINER RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol 2006; 4:566–572.
- 5. SARACI G, STEFAN C, PASCU O. Epidemiologic aspects in esophageal pathology focusing on gastroesophageal reflux disease and Barrett’s esophagus. HVM Bioflux, 2011, vol. 3, issue 2.
- 6. CIOBOTARU OR, VOINESCU DC, CIOBOTARU OC, VOICU D, ARBUNE M. Expression of p53 and Ki-67 in distal oesophageal and gastric cardia adenocarcinomas. Romanian Biotechnologival Letters, Vol. 20, No. 5, 2015.
- 7. HOARA P, BIRLA R, GINDEA C, CONSTANTIN A, PANAITESCU G, IORDAN N, CONSTANTINOIU S. The role of esophageal manometry in the management of the patients with gastro-eophageal reflux disease and Barrett’s esophagus. Chirurgia (Bucur). 2008, 103(4):407–12.
- 8. PASCARENCO O, DOBRU D, BOERIU A, BRUSNIC O, GALEANU I, ONISOR D ET AL. The usefulness of magnifying chromoendoscopy with methylene blue in the detection of specialized intestinal metaplasia and dysplasia in Barrett’s Esophagus – a preliminary report. AMM 2012, Vol. 58, No 3.
- 9. PETRISOR C.A, MICU-TUDORICA S, ENACHESCU V, CIUREA P, GHEONEA D. The role of narrow band imaging in Barrett esophagus diagnosis. Practica Medicala, Vol. VII, No 1(25), 2012.
- 10. PASCARENCO O, DOBRU D, BOERIU A, BRUSNIC O, ONISOR D, STOIAN M et al. The importance of magnification chromoendoscopy with methylene blue in detecting specialized intestinal metaplasia in short segment Barrett’s esophagus. HVM Bioflux 4(1):40–44.
- 11. PASCARENCO O, BOERIU A, MOCAN S, PASCARENCO G, DRASOVEANU S, GALEANU M ET AL. Barrett’s Esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features. J Gastrointest Liver Dis. 2014, Vol. 23, No 1:19–25.
- 12. PASCARENCO O, COROS MF, PASCARENCO G, BOERIU A, DRASOVEAN S, ONISOR D et al. A preliminary feasibility study: narrow-band imaging targeted versus standard white light endoscopy non-targeted biopsies in a surveillance Barrett’s population. Digestive and Liver dis, 2016.
- 13. GINDEA C, BIRLA R, HOARA P, CARAGUL A, CONSTANTINIU S. Barrett Esophagus: history, definition and etiopathogeny. Journal of Medicine and Life Vol. 7, Special Issue 3, 2014.
- 14. PASCU O. Boala de reflux gastroesofagian. Esenţialul în Gastroenterologie şi Hepatologie. Ed Naţional Buc 2003:4.
- 15. PASCU O. Tratamentul bolii de reflux gastro-esofagian. Br Med J (ed. ro) 2002; 7:308–312.
- 16. PASCU O, LENCU M. Barrett’s Esophagus. Rom J. Gastroenterol. 2004; 13(3):219–22.
- 17. TANTAU M, LASZLO M, TANTA A. Barrett’s Esophagus-state of the art. Chirurgia (Bucur) 2018; 113:46–60.
- 18. IRELAND CJ, THOMPSON SK, LAWS TA, ESTERMAN A. Risk factors for Barrett’s esophagus: a scoping review. Cancer Causes Control 2016; 27(3):301–23.
- 19. ELOUBEIDI M.A, PROVENZALE D, Clinical and demographic predisctors of Barrett’s esophagus among paients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol 2001; 33:306–309.
- 20. WESTHOFF B, BROTZE S, WESTON A, MCELHINNEY C, CHERIAN R, MAYO M.S, ET AL. The frequency of Barrett’sesophagus in high-risk patients with chronic GERD. Gastrointest Endosc 2005; 61(2):226–31.
- 21. ANDRICI J, TIO M, COX MR, ESLIK GD. Hiatal hernia and the risk of Barrett’s esophagus. J Gastroenterol Hepatol. 2013; 28(3):415–31.
- 22. GRAHAM DY, YAMAOKA Y. H. pylori and cagA: relationships with gastric cancer, duodenal cancer and reflux esophagitis and its complications. Helicobacter 1998; 3:145–51.
- 23. TULASSAY Z, STOLTE M, ENGSTRAND L, BUTRUK E, MALFERHEINER P, DITE P ET AL. Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. Scand J Gastroenterol 2010; 45:1048–1058.
- 24. SHARMA P, DENT J, ARMSTRONG D, BERGMAN JJ, GLOSSNER L, HOSHIHARA Y ET AL. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C&M criteria. Gatroenterology 2006; 131(5):1392.
- 25. BALDAQUE SF, MARQUES M, LUNET N, THEMUDO G, GODA K, TOTH E ET AL. Endoscopic assessment and grading of Barrett’s esophagus using magnification endoscopy and narrow band imaging: impact of structured learning and experience of the accuracy of the Amsterdam classification system. Scandinavian J Gastroenterol 2012; 48(2):160–167.
- 26. SHARMA P, BENSAL A, MARTHUR S, WANI S, CHERIAN R, MCGREGOR D ET AL. The utility of a novel narrow band imaging endoscopy system in patients with Barrett’s esophagus. Gastrintest Endosc 2006; 64:167–75.
- 27. SCHEMPLER R, RIDDELL R, KATO Y, BORCHARD F, COOPER H, DAWSEY S et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47(2):251–255.
- 28. BOERIU A, BRUSNIC O, ONISOR D, PASCARENCO O, BOERIU C, DOBRU D. The usefulness of white light endoscopy, narrow band imaging and magnification for the optimization of diagnosis in Barrettt’s esophagus. Acta Medica Marisiensis 2014; 60(6):244–248.
- 29. FITZGERALD RD, DI PIETRO M, RAGAUNATH K, ANG Y, KANG JY, WATSON P et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s esophagus. Gut 2014; 63(1):7–42
- 30. ENDO T, AWAKAWA T, TAKAHASHI H, ITOH F, YAMASHITA K, SASAKI S et al. Classification of Barrett’s epithelium by magnifying endoscopy. Gastointest Endosc 2002; 55(6):641–7.
- 31. TANTAU M., LASZLO M, TANTA A. Barrett’s Esophagus-state of the art. Chirurgia (Bucur) 2018; 113:46–60.
- 32. BAZIN C, BENEZECH A, ALESSANDRINI M, GRIMAUD JC, VITTON V. Esophageal motor disorders are a strong independent associated factor of Barret’s esophagus. J Neurogastroent Motil 2018; 30; 24(2):216–225.
Language: English
Page range: 111 - 118
Submitted on: Mar 23, 2019
Published on: Aug 10, 2020
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 Claudia Piloiu, Dan L. Dumitrascu, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.